36C24823N0672↗

Name: 36C24823N0672: Bpa for Alinity M Sars-Cov-2/Hiv Reagents.
Creator: SpendQuery

BPA FOR ALINITY M SARS-COV-2/HIV REAGENTS.

Bpa Call · Department of Veterans Affairs · to Abbott Laboratories Inc. (UEI NH3LDK8CFAK7) · data as of 2026-09-30

Obligated to date$767.2K3 actions

Current value$767.2Kwith options exercised

Period2023-06-30 → 2024-06-30current end date

What it is

Product or service: In Vitro Diagnostic Substances, Reagents, Test Kits and Sets (PSC 6550)
Industry: Analytical Laboratory Instrument Manufacturing (NAICS 334516)
Contracting office: 248-Network Contract Office 8 (36C248) (36C248)
Competition: Full and open competition
Pricing: Firm fixed price
How it was bought: Blanket purchase agreement (BPA) · under 36C24822A0030
Where the work is: Cook, IL · district IL-08
Topics: covid

Obligations by fiscal year

FY2023$2.37M

FY2024-$1.60M

SpendQuery holds FY2023 on; earlier years are on USAspending.gov.

Subcontractors: where the money went next

No subawards reported for this award. Primes report subawards of $30,000 or more; many awards have none.

Every action

3 actions since 2023-06-07. Each is a modification or amendment with the money it added or took back.

Date	Modification	Kind	Amount	What the agency wrote
2024-09-12	P00002	Funding only	-$198.2K	BPA FOR ALINITY M SARS-COV-2/HIV REAGENTS.
2024-03-06	P00001	Supplemental agreement (work within scope)	-$1.41M	BPA FOR ALINITY M SARS-COV-2/HIV REAGENTS.
2023-06-07	0		$2.37M	BPA FOR ALINITY M SARS-COV-2/HIV REAGENTS.

Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-09-30). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗